Terms: = Germ cell tumor AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Treatment
116 results:
1. [Relationship between PD-L1 expression and tumor stem cell marker CD44 as a promising basis for the development of new approaches to cancer targeted therapy].
Sotnikova TN; Polushkina TV; Danilova NV
Arkh Patol; 2023; 85(6):70-75. PubMed ID: 38010641
[TBL] [Abstract] [Full Text] [Related]
2. A Novel Technology for 3D-Printing Artificial Vertebral Bodies for Treating Lumbar Spine Adrenal Pheochromocytoma Metastases: A Case Report and Review of the Literature.
Zhang Y; Li H; Wang W; Shan L; Hao D
Orthop Surg; 2023 Dec; 15(12):3335-3341. PubMed ID: 37771116
[TBL] [Abstract] [Full Text] [Related]
3. Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults.
Stiefel J; Kushner BH; Roberts SS; Iglesias-Cardenas F; Kramer K; Modak S
JCO Precis Oncol; 2023 Aug; 7():e2300138. PubMed ID: 37561984
[TBL] [Abstract] [Full Text] [Related]
4. CD71
Bozorgmehr N; Okoye I; Mashhouri S; Lu J; Koleva P; Walker J; Elahi S
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37236637
[TBL] [Abstract] [Full Text] [Related]
5. Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.
Park JS; Gazzaniga FS; Wu M; Luthens AK; Gillis J; Zheng W; LaFleur MW; Johnson SB; Morad G; Park EM; Zhou Y; Watowich SS; Wargo JA; Freeman GJ; Kasper DL; Sharpe AH
Nature; 2023 May; 617(7960):377-385. PubMed ID: 37138075
[TBL] [Abstract] [Full Text] [Related]
6. Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study.
Yang DD; Liu C; Gao J; Hu QJ; Liang Y; Liu J
Eur J Pediatr; 2023 May; 182(5):2189-2196. PubMed ID: 36856889
[TBL] [Abstract] [Full Text] [Related]
7. Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
Cui C; Chen Y; Luo Z; Zou Z; Jiang Y; Pan H; Fan Q; Zhao J; Xu Q; Jiang R; Wang X; Ma T; Guo Z; Si L; Chi Z; Sheng X; Dou Y; Tan Q; Wu D; Guo J
BMC Cancer; 2023 Feb; 23(1):121. PubMed ID: 36747118
[TBL] [Abstract] [Full Text] [Related]
8. Programmed cell death-1 blockade therapy in melanoma: Resistance mechanisms and combination strategies.
Zou Y; Yaguchi T
Exp Dermatol; 2023 Mar; 32(3):264-275. PubMed ID: 36645031
[TBL] [Abstract] [Full Text] [Related]
9. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
[TBL] [Abstract] [Full Text] [Related]
10. Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines.
Schatz J; Ladinig A; Fietkau R; Putz F; Gaipl US; Frey B; Derer A
Strahlenther Onkol; 2023 Dec; 199(12):1140-1151. PubMed ID: 36480032
[TBL] [Abstract] [Full Text] [Related]
11. Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia.
Burgess M; Keane C; Tobin JW; Law SC; Griffin A; Gill D; Ewing AD; Atkinson V; Mollee P; Sabdia MB; Saunders NA; Gandhi MK
Acta Haematol; 2023; 146(2):166-171. PubMed ID: 36273464
[TBL] [Abstract] [Full Text] [Related]
12. Testicular yolk sac tumour metastasis to the L2 vertebra.
Murray G; De Jesus O; Correa-Rivas M; Cheverez-Ocasio JI
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36135998
[TBL] [Abstract] [Full Text] [Related]
13. CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
de Vos L; Carrillo Cano TM; Zarbl R; Klümper N; Ralser DJ; Franzen A; Herr E; Gabrielpillai J; Vogt TJ; Dietrich J; Strieth S; Landsberg J; Dietrich D
J Immunother; 2022 Sep; 45(7):324-334. PubMed ID: 35862127
[TBL] [Abstract] [Full Text] [Related]
14. Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas.
Weishaupt H; Čančer M; Rosén G; Holmberg KO; Häggqvist S; Bunikis I; Jiang Y; Sreedharan S; Gyllensten U; Becher OJ; Uhrbom L; Ameur A; Swartling FJ
Neuro Oncol; 2023 Jan; 25(1):97-107. PubMed ID: 35738865
[TBL] [Abstract] [Full Text] [Related]
15. Preclinical platforms to study therapeutic efficacy of human γδ T cells.
Ou L; Wang H; Huang H; Zhou Z; Lin Q; Guo Y; Mitchell T; Huang AC; Karakousis G; Schuchter L; Amaravadi R; Guo W; Salvino J; Herlyn M; Xu X
Clin Transl Med; 2022 Jun; 12(6):e814. PubMed ID: 35731974
[TBL] [Abstract] [Full Text] [Related]
16. PD-L1 in gestational trophoblastic disease: an antibody evaluation.
Hoeijmakers YM; Simons M; Bulten J; Gorris MAJ; Ottevanger PB; de Vries IJM; Sweep FCGJ
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):1007-1016. PubMed ID: 35689468
[TBL] [Abstract] [Full Text] [Related]
17. Detailed
Stoll E; Hader M; Rückert M; Weissmann T; Lettmaier S; Putz F; Hecht M; Fietkau R; Rosin A; Frey B; Gaipl US
Int J Hyperthermia; 2022; 39(1):796-805. PubMed ID: 35676615
[TBL] [Abstract] [Full Text] [Related]
18. Long Non-coding RNA and mRNA Co-expression Network Reveals Novel Players in Pleomorphic Xanthoastrocytoma.
Dandapath I; Gupta R; Singh J; Shukla N; Jha P; Sharma V; Suri A; Sharma MC; Suri V; Sarkar C; Kulshreshtha R
Mol Neurobiol; 2022 Aug; 59(8):5149-5167. PubMed ID: 35674862
[TBL] [Abstract] [Full Text] [Related]
19. Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study.
Rossi E; Zizzari IG; Di Filippo A; Acampora A; Pagliara MM; Sammarco MG; Simmaco M; Lionetto L; Botticelli A; Bria E; Marchetti P; Blasi MA; Tortora G; Schinzari G; Nuti M
Hum Vaccin Immunother; 2022 May; 18(3):2034377. PubMed ID: 35258435
[TBL] [Abstract] [Full Text] [Related]
20. The Fairy Chemical Imidazole-4-carboxamide Inhibits the Expression of Axl, PD-L1, and PD-L2 and Improves Response to Cisplatin in Melanoma.
Inoue C; Yasuma T; D'Alessandro-Gabazza CN; Toda M; Fridman D'Alessandro V; Inoue R; Fujimoto H; Kobori H; Tharavecharak S; Takeshita A; Nishihama K; Okano Y; Wu J; Kobayashi T; Yano Y; Kawagishi H; Gabazza EC
Cells; 2022 Jan; 11(3):. PubMed ID: 35159184
[TBL] [Abstract] [Full Text] [Related]
[Next]
